Microglia LILRB4 upregulation reduces brain damage after acute ischemic stroke by limiting CD8+ T cell recruitment
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The microglial sensome revealed by direct RNA sequencing
Hickman, S. E., Kingery, N. D., Ohsumi, T. K., Borowsky, M. L., Wang, L.-C., Means, T. K., & El Khoury, J. (2013) · Nature Neuroscience · doi:10.1038/nn.3554 · Cited by 1,511
Li, Q., Cheng, Z., Zhou, L., Darmanis, S., Neff, N. F., Okamoto, J., Gulati, G., Bennett, M. L., Sun, L. O., Clarke, L. E., et al. (2019) · Neuron · doi:10.1016/j.neuron.2018.12.006 · Cited by 1,129
Epigenetic regulation of brain region-specific microglia clearance activity
Ayata, P., Badimon, A., Strasburger, H. J., Duff, M. K., Montgomery, S. E., Loh, Y.-H. E., Ebert, A., Pimenova, A. A., Ramirez, B. R., Chan, A. T., et al. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0192-3 · Cited by 460
LILRB4 signalling in leukaemia cells mediates T cell suppression and tumour infiltration
Deng, M., Gui, X., Kim, J., Xie, L., Chen, W., Li, Z., He, L., Chen, Y., Chen, H., Luo, W., et al. (2018) · Nature · doi:10.1038/s41586-018-0615-z · Cited by 305 · cited 5×
“…we observed the function state of cytotoxic CD8 + T cells was inhibited by LILRB4 in microglia, which was in line with the results of previous studies demonstrating that LILRB4 signaling inhibited CD8 + T cell cytotoxicity and infiltration in leukemia cells and cancer progression [14, 17].”
BackgroundResultInfluentialJorfi, M., Park, J., Hall, C. K., Lin, C.-C. J., Chen, M., von Maydell, D., Kruskop, J. M., Kang, B., Choi, Y., Prokopenko, D., et al. (2023) · Nature Neuroscience · doi:10.1038/s41593-023-01415-3 · Cited by 214
Han, B., Zhou, S., Zhang, Y., Chen, S., Xi, W., Liu, C., Zhou, X., Yuan, M., Yu, X., Li, L., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adg1323 · Cited by 143 · cited 2×
“Disease-associated microglia (DAM) subsets [7, 8] have been identified by scRNA-seq in various nervous system diseases.”
BackgroundResultSelf-citation
Research works printed but not linked: 50
- Fan J et al. Global Burden, risk factor analysis, and Prediction Study of ischemic stroke, 1990–2030. Neurology. 2023;101(2). · DOI · Paper page
- Mun KT, Hinman JD. Inflammation and the link to vascular Brain Health: timing is brain. Stroke. 2022;53(2):427–36. · DOI
- Lee J, McCullough LD. Revisiting regulatory T cells for stroke therapy. J Clin Invest. 2022;132(15). · DOI
- Zheng P, et al. Group 2 innate lymphoid cells resolve neuroinflammation following cerebral ischaemia. Stroke Vasc Neurol. 2023. · DOI
- Zhang G, et al. Spi1 regulates the microglial/macrophage inflammatory response via the PI3K/AKT/mTOR signaling pathway after intracerebral hemorrhage. Neural Regen Res. 2024;19(1):161–70. · DOI
- Hu X, et al. Microglia/macrophage polarization dynamics reveal novel mechanism of injury expansion after focal cerebral ischemia. Stroke. 2012;43(11):3063–70. · DOI · Paper page
- Garcia-Bonilla L et al. Analysis of brain and blood single-cell transcriptomics in acute and subacute phases after experimental stroke. Nat Immunol. 2024. · DOI
- Keren-Shaul H, et al. A unique microglia type associated with restricting development of Alzheimer’s Disease. Cell. 2017;169(7):1276–e129017. · DOI · Paper page
- Mifflin L, et al. A RIPK1-regulated inflammatory microglial state in amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A, 2021;118(13). · DOI · Paper page
- Daëron M, et al. Immunoreceptor tyrosine-based inhibition motifs: a quest in the past and future. Immunol Rev. 2008;224:11–43. · DOI · Paper page
- Coxon CH, Geer MJ, Senis YA. ITIM receptors: more than just inhibitors of platelet activation. Blood. 2017;129(26):3407–18. · DOI · Paper page
- Xu Z, et al. ILT3.Fc-CD166 Interaction induces inactivation of p70 S6 kinase and inhibits Tumor Cell Growth. J Immunol. 2018;200(3):1207–19. · DOI
- Su MT, et al. Fibronectin-LILRB4/gp49B interaction negatively regulates osteoclastogenesis through inhibition of RANKL-induced TRAF6/TAK1/NF-kB/MAPK signaling. Int Immunol. 2023;35(3):135–45. · DOI
- Wang Y et al. Discovery of galectin-8 as an LILRB4 ligand driving M-MDSCs defines a class of antibodies to fight solid tumors. Cell Rep Med, 2024. 5(1). · DOI
- Zhou H, et al. Leukocyte immunoglobulin-like receptor B4 protects against cardiac hypertrophy via SHP-2-dependent inhibition of the NF-kappaB pathway. J Mol Med (Berl). 2020;98(5):691–705. · DOI
- Qiu T et al. Leukocyte immunoglobulin-like receptor B4 deficiency exacerbates acute lung injury via NF-κB signaling in bone marrow-derived macrophages. Biosci Rep. 2019:39(6). · DOI
- Lu Y, et al. Hepatic leukocyte immunoglobulin-like receptor B4 (LILRB4) attenuates nonalcoholic fatty liver disease via SHP1-TRAF6 pathway. Hepatology. 2018;67(4):1303–19. · DOI
- Lee HN et al. NK cells require immune checkpoint receptor LILRB4/gp49B to control neurotropic Zika virus infections in mice. JCI Insight. 2022;7(3). · DOI
- Sharma N et al. LILRB4 suppresses immunity in solid tumors and is a potential target for immunotherapy. J Exp Med. 2021;218(7). · DOI · Paper page
- Xu Z, et al. Suppression of experimental autoimmune encephalomyelitis by ILT3.Fc. J Immunol. 2021;206(3):554–65. · DOI
- Jiang Z et al. LILRB4 deficiency aggravates the development of atherosclerosis and plaque instability by increasing the macrophage inflammatory response via NF-kappaB signaling. Clin Sci (Lond), 2017. · DOI
- Butler A, et al. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat Biotechnol. 2018;36(5):411–20. · DOI · Paper page
- Kirschbaum KM, Hiemke C, Schmitt U. Rotarod impairment: catalepsy-like screening test for antipsychotic side effects. Int J Neurosci. 2009;119(10):1509–22. · DOI
- Kim DH, et al. Assessment of cognitive phenotyping in inbred, genetically modified mice, and transgenic mouse models of Alzheimer’s Disease. Exp Neurobiol. 2019;28(2):146–57. · DOI
- Rosa I et al. Comparison between tail suspension swing test and standard rotation test in revealing early motor behavioral changes and neurodegeneration in 6-OHDA hemiparkinsonian rats. Int J Mol Sci. 2020;21(8). · DOI
- Horiquini Barbosa E, et al. Assessments of Motor abnormalities on the Grid-walking and Foot-Fault tests from Undernutrition in Wistar rats. J Mot Behav. 2016;48(1):5–12. · DOI
- Ruan J, Yao Y. Behavioral tests in rodent models of stroke. Brain Hemorrhages. 2020;1(4):171–84. · DOI · Paper page
- Bieber M, et al. Validity and reliability of neurological scores in mice exposed to Middle cerebral artery occlusion. Stroke. 2019;50(10):2875–82. · DOI · Paper page
- Chang CC, et al. BCL6 is required for differentiation of Ig-like transcript 3-Fc-induced CD8+ T suppressor cells. J Immunol. 2010;185(10):5714–22. · DOI
- Vlad G, et al. Membrane and soluble ILT3 are critical to the generation of T suppressor cells and induction of immunological tolerance. Int Rev Immunol. 2010;29(2):119–32. · DOI · Paper page
- Kim-Schulze S, et al. Recombinant Ig-like transcript 3-Fc modulates T cell responses via induction of Th anergy and differentiation of CD8+ T suppressor cells. J Immunol. 2006;176(5):2790–8. · DOI · Paper page
- Shi Z, et al. Microglia drive transient insult-induced brain injury by chemotactic recruitment of CD8(+) T lymphocytes. Neuron. 2023;111(5):696–e7109. · DOI · Paper page
- Su W, et al. CXCR6 orchestrates brain CD8+ T cell residency and limits mouse Alzheimer’s disease pathology. Nat Immunol. 2023;24(10):1735–47. · DOI · Paper page
- Mussai F, et al. Acute myeloid leukemia creates an arginase-dependent immunosuppressive microenvironment. Blood. 2013;122(5):749–58. · DOI · Paper page
- Chamorro A, et al. The immunology of acute stroke. Nat Rev Neurol. 2012;8(7):401–10. · DOI · Paper page
- Butowski N, et al. Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study. Neurooncology. 2016;18(4):557–64.
- Beuker C, et al. Stroke induces disease-specific myeloid cells in the brain parenchyma and pia. Nat Commun. 2022;13(1):945. · DOI · Paper page
- Zheng K et al. Single-cell RNA-seq reveals the transcriptional landscape in ischemic stroke. J Cereb Blood Flow Metab, 2021:271678X211026770. · DOI · Paper page
- Su MT, et al. LILRB4 promotes tumor metastasis by regulating MDSCs and inhibiting miR-1 family miRNAs. Oncoimmunology. 2022;11(1):2060907. · DOI
- Li Q, Wei G, Tao T. Leukocyte immunoglobulin-like receptor B4 (LILRB4) negatively mediates the pathological cardiac hypertrophy by suppressing fibrosis, inflammation and apoptosis via the activation of NF-kappaB signaling. Biochem Biophys Res Commun. 2019;509(1):16–23. · DOI
- Li D, et al. Upregulation of Microglial ZEB1 ameliorates brain damage after Acute ischemic stroke. Cell Rep. 2018;22(13):3574–86. · DOI
- Cui P, et al. Microglia/macrophages require vitamin D signaling to restrain neuroinflammation and brain injury in a murine ischemic stroke model. J Neuroinflammation. 2023;20(1):63. · DOI
- Li M, et al. Astrocyte-derived interleukin-15 exacerbates ischemic brain injury via propagation of cellular immunity. Proc Natl Acad Sci U S A. 2017;114(3):E396–405. · DOI · Paper page
- Chang CC, et al. Ig-like transcript 3 regulates expression of proinflammatory cytokines and migration of activated T cells. J Immunol. 2009;182(9):5208–16. · DOI · Paper page
- Czystowska-Kuzmicz M, et al. Small extracellular vesicles containing arginase-1 suppress T-cell responses and promote tumor growth in ovarian carcinoma. Nat Commun. 2019;10(1):3000. · DOI · Paper page
- Naing A et al. 747 A phase 1 trial of IO-202, an antagonist antibody targeting myeloid checkpoint LILRB4 (ILT3), as monotherapy and in combination with pembrolizumab in adult patients with advanced relapsed or refractory solid tumors. In Regular and Young Investigator Award Abstracts. 2022. pp. A780-A780. · DOI
- Russo RS, et al. Efficacy and safety of pegzilarginase in arginase 1 deficiency (PEACE): a phase 3, randomized, double-blind, placebo-controlled, multi-centre trial. EClinicalMedicine. 2024;68:102405. · DOI
- Arm JP, Nwankwo C, Austen KF. Molecular identification of a novel family of human ig superfamily members that possess immunoreceptor tyrosine-based inhibition motifs and homology to the mouse gp49B1 inhibitory receptor. J Immunol. 1997;159(5):2342–9. · DOI · Paper page
- Hou, J., et al., Antibody-mediated targeting of human microglial leukocyte Ig-like receptor B4 attenuates amyloid pathology in a mouse model. Sci Transl Med, 2024. 16(741): p. eadj9052. · DOI
- Bonkhoff AK, et al. Outcome after acute ischemic stroke is linked to sex-specific lesion patterns. Nat Commun. 2021;12(1):3289. · DOI
Metadata
- Authors
- Ma, Y., Zheng, K., Zhao, C., Chen, J., Chen, L., Zhang, Y., Chen, T., Yao, X., Cai, Y., & Wu, J.
- Venue
- Journal of Neuroinflammation
- Published
- 2024-08-31
- Volume
- 21
- Issue
- 1
- ISSN
- 1742-2094
- Cited by
- 55
- References
- 6
- Language
- en
- Licence
- creativecommons.org/licenses/by-nc-nd/4.0 (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0 (vor)
- Funders
- National Natural Science Foundation of China (82201442, 82371320)
- Tianjin Key Medical Discipline (Specialty) Construction Project (TJYXZDXK-052B)
- Tianjin Natural Science Foundation (23JCZXJC00110)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.